Related Experiment Video
Updated: Mar 29, 2026

Author Spotlight: Advancing Endoscopic Ossiculoplasty – Techniques, Innovations, and Practical Guidance for Clinical Integration
Published on: January 26, 2024
[The eosinophilic otitis media's research progress]
Abstract:
The eosinophilic otitis media(EOM) is an intractable disease characterized by the presence of a highly viscous yellow effusion with extensive accumulation of eosinophils in the middle ear; granulation tissue can been discovered in the middle ear cavity; most of patients have association with bronchial asthma; resist to conventional treatment for otitis media; EOM patients show gradual deterioration of hearing and sometimes become deaf suddenly; effective treatment involves use of topical and oral steroids. This article summarizes the progress of the EOM's diagnosis and treatment.
Insights
Eosinophilic otitis media (EOM) is a difficult-to-treat condition causing hearing loss, often linked to asthma. Effective management focuses on steroid treatments, with this review covering current diagnostic and therapeutic advances.
Area of Science:
- Otolaryngology
- Allergy Immunology
Background:
- Eosinophilic otitis media (EOM) is a severe middle ear disease.
- Characterized by viscous effusion, eosinophil infiltration, and granulation tissue.
- Often associated with bronchial asthma and resistant to standard treatments.
Purpose of the Study:
- To review current diagnostic approaches for EOM.
- To summarize effective treatment strategies for EOM.
- To highlight advances in managing this intractable condition.
Main Methods:
- Literature review of diagnostic criteria for EOM.
- Analysis of treatment outcomes for EOM.
- Synthesis of current research on EOM management.
Main Results:
- EOM diagnosis relies on characteristic effusion and eosinophil presence.
- Steroid therapy (topical and oral) is the mainstay of effective EOM treatment.
- EOM can lead to progressive or sudden hearing loss.
Conclusions:
- Early diagnosis and prompt steroid treatment are crucial for EOM.
- Further research is needed to understand EOM pathogenesis and improve therapies.
- Multidisciplinary management involving allergists and otolaryngologists is recommended.
Related Concept Videos
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:

